Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]
Topics covered
Popular Clips
Episode Highlights
Gene Editing
Gene editing technologies like CRISPR are revolutionizing the treatment landscape by enabling precise modifications to DNA. explains how these technologies can potentially cure diseases like muscular atrophy by inserting functional genes into cells that lack them 1. However, the challenge lies in effectively delivering these genes into the target cells, often requiring innovative delivery methods such as using viruses 1. highlights the potential of gene therapies, noting that although there are few commercial successes now, the future holds promise for more breakthroughs 2.
The big tension in how you regulate drugs is how do you balance the need to develop drugs quickly, while also keeping patients who are participating in clinical trials safe.
---
The evolution of these technologies is expected to significantly impact drug development timelines, potentially shortening the time from discovery to implementation 2.
Complex Therapies
Complex therapies, such as CAR T-cell therapy, represent a significant advancement in personalized medicine. describes the intricate process of extracting immune cells, editing them to target cancer cells, and reinfusing them into the patient 3. This high-touch process requires significant expertise and infrastructure, making it more complex than traditional pharmaceuticals 3. Radiopharmaceuticals, another cutting-edge therapy, involve targeting cancer cells with radiation-emitting compounds, demanding precise manufacturing and delivery due to their short half-life 3.
The high touch process, expertise and scale you need to deliver these super complex next generation therapies like CAR T's, like gene therapy that are somewhat personalized, is just way beyond traditional pharma.
---
These therapies are not only transforming treatment options but also redefining the pharmaceutical industry's approach to drug development and delivery 4.